Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Italfarmaco To Seek Givinostat Approvals After Phase III Success In DMD
Capricor Reported Long-Term Data For Its Cell Therapy
Jun 28 2022
•
By
Mandy Jackson
Italfarmaco's givinostat succeeded across all muscle function measures • Source: Shutterstock
More from Clinical Trials
More from R&D